共 13 条
[1]
Detenbeck L.C., Tressler H.A., O'Duffy J.D., Randall R.V., Peripheral joint manifestations of acromegaly, Clin. Orthop., 91, pp. 119-127, (1973)
[2]
Podgorski M., Robinson B., Weissberger A., Stiel J., Wang S., Brooks P.M., Articular manifestations of acromegaly, Aust. N. Z. J. Med., 18, pp. 28-35, (1988)
[3]
Layton M.W., Fudman E.J., Barkan A., Braunstein E.M., Fox I.H., Acromegalic arthropathy. Characteristics and response to therapy, Arthritis Rheum., 31, pp. 1022-1027, (1988)
[4]
Okazaki K., Jingushi S., Ikenoue T., Urabe K., Sakai H., Ohtsuru A., Akino K., Yamashita S., Nomura S., Iwamoto Y., Expression of insulin-like growth factor 1 messenger ribonucleic acid in developing osteophytes in murine experimental osteoarthritis and in rats inoculated with growth hormone-secreting tumor, Endocrinology, 140, pp. 4821-4830, (1999)
[5]
Peterson M.E., Taylor R.S., Greco D.S., Nelson R.W., Randolph J.F., Foodman M.S., Moroff S.D., Morrison S.A., Lothrop C.D., Acromegaly in 14 cats, J. Vet. Intern. Med., 4, pp. 192-201, (1990)
[6]
Bagge E., Eden S., Rosen T., Bengtsson B.A., The prevalence of radiographic osteoarthritis is low in elderly patients with growth hormone deficiency, Acta Endocrinol., 129, pp. 296-300, (1993)
[7]
Dons R.F., Rosselet P., Pastakia B., Doppman J., Gorden P., Arthropathy in acromegalic patients before and after treatment: A long-term follow-up study, Clin. Endocrinol., 28, pp. 515-524, (1988)
[8]
Chipman J.J., Attanasio A.F., Birkett M.A., Bates P.C., Webb S., Lamberts S.W., The safety profile of GH replacement therapy in adults, Clin. Endocrinol., 46, pp. 473-481, (1997)
[9]
Johanson N.A., Vigorita V.J., Goldman A.B., Salvati E.A., Acromegalic arthropathy of the hip, Clin. Orthop., 173, pp. 130-139, (1983)
[10]
Lacks S., Jacobs R.P., Acromegalic arthropathy: A reversible rheumatic disease, J. Rheumatol., 13, pp. 634-636, (1986)